PDL BioPharma chooses post-spinoff CEO

11/6/2008 | Forbes

John McLaughlin will take over as president and CEO of PDL BioPharma after the company spins off its biotech assets. McLaughlin, who held positions at Genentech and Anesiva, began serving on PDL's board of directors in October.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ